{
    "accession": "ENCBS454CXD",
    "age": "15",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "interference",
            "method": "RNAi",
            "modified_site_by_target_id": "RBM22",
            "purpose": "repression",
            "reagents": [
                {
                    "identifier": "trc:TRCN0000232010",
                    "source": "/sources/trc/",
                    "url": "http://www.broadinstitute.org/rnai/public/clone/details?cloneId=TRCN0000232010"
                }
            ]
        }
    ],
    "biosample_term_id": "EFO:0001187",
    "biosample_term_name": "HepG2",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "RNA-seq on HepG2 cells treated with an shRNA knockdown against RBM22. (RBM22_BGHLV37-50)",
    "documents": [
        {
            "attachment": "/documents/23677fe8-e7c7-4475-a5c6-87209fbd3a72/@@download/attachment/RBM22_BGHLV37-50_update.pdf",
            "document_type": "general protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000AAC",
    "health_status": "hepatocellular carcinoma",
    "lab": "Brenton Graveley, UConn",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "ATCC",
    "summary": "Homo sapiens HepG2 cell line expressing RNAi targeting RBM22",
    "treatments": []
}